Skip to main content

Table 3 Patients’ mean (standard deviation) blood pressure and health-related quality of life status *

From: Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

 

Baseline

Week 54

Difference between week 54 and baseline

p value derived using a t-test

Systolic blood pressure

168.4 (6.6)

127.1 (9.0)

−41.3 (10.0)

<0.0001

Diastolic blood pressure

103.8 (2.9)

78.0 (6.6)

−25.9 (6.9)

<0.0001

EQ-5D index

0.90 (0.13)

0.95 (0.11)

0.05 (0.12)

<0.0001

EQ-5D VAS

73.4 (15.0)

82.3 (12.5)

8.9 (14.4)

<0.0001

MINICHAL mood domain

5.45 (4.42)

3.68 (3.74)

−1.80 (4.24)

<0.0001

MINICHAL somatic domain

2.62 (2.66)

1.80 (2.16)

−0.80 (2.46)

<0.0001

MINICHAL total score

8.00 (6.22)

5.40 (5.12)

−2.60 (5.68)

<0.0001

  1. *Not all patients completed all HRQoL instruments at each time point.